All subcategories » Cochrane Review
- 2022
- Yang Connie
Interventions for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis
Cochrane Database of Systematic Reviews - Cochrane Review
Details- 2026
- Lo David KH
CFTR modulator monotherapy for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del)
Cochrane Database of Systematic Reviews - Cochrane Review
Details- 2026
- Matthew Heneghan
Lung transplant in people with cystic fibrosis and nontuberculous mycobacteria infection.
Cochrane Database of Systematic Reviews - Cochrane Review
Details- 2026
- Safavi S
Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis
Cochrane Database of Systematic Reviews - Cochrane Review
Details- 2025
- Calthorpe R
Non-invasive ventilation for cystic fibrosis
Cochrane Database of Systematic Reviews - Cochrane Review
Details- 2025
- AS Sousa
Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis
Cochrane Database of Systematic Reviews - Cochrane Review
Details- 2025
- Hurley Matthew N
Bronchoscopy-guided antimicrobial therapy for cystic fibrosis
Cochrane Database of Systematic Reviews - Cochrane Review
Details- 2024
- Jain K
Macrolide antibiotics (including azithromycin) for cystic fibrosis
Cochrane Database of Systematic Reviews - Cochrane Review
Details- 2024
- Southern K W
Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del)
Cochrane Database of Systematic Reviews - Cochrane Review
Details- 2023
- Southern KW